AcuCort joins Röda webben ahead of commercialization
AcuCort has joined the Röda webben services which is coordinated by the industry organization for pharmaceutical companies conducting research - LIF. The affiliation is a step towards the upcoming commercialization of the company's pharmaceutical product Zeqmelit®.Within the pharmaceutical industry, there are elaborate complaint and recall procedures. The guidelines are collected on the so-called Röda webben and describe how complaints and withdrawals of medicines should be handled in Sweden. These guidelines constitute standards for the pharmaceutical industry with products on the Swedish